Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment Support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    PCF-Pfizer Health Equity Challenge Awards
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Research Oncology All
    Shared Decision Making Including Financial Cost and Cancer Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Early Identification and Diagnosis of Axial Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    BRAF-mutant melanoma: treatment selection and side effect management
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan